AB050. SHR-1316 plus nab-paclitaxel and carboplatin as the first line therapy for advanced, unresectable, recurrent or metastatic thymic carcinoma - Xu, Ning; Fang, Wentao (Mediastinum; Vol 8 (December 30, 2024): Mediastinum [Abstract Book for the 14th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2024)], 2024)